In contrast, T0901317 activated LXRα inhibits alpha-smooth muscle actin or α-SMA (ACTA2) and negatively regulates the TGFβ differentiation in HCC resulting in the increase in the fatty acid synthase (FASN) expression levels the inhibition of tumour growth (Morén et al., 2019). Here, FASN is linked to hepatocellular carcinoma.